help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 51, No. 3 620-625
doi:10.1210/jcem-51-3-620
Copyright © 1980 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GEOLA, F. L.
Right arrow Articles by JUDD, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GEOLA, F. L.
Right arrow Articles by JUDD, H. L.

Biological Effects of Various Doses of Conjugated Equine Estrogens in Postmenopausal Women*

FLOR L. GEOLA, ANTHONY M. FRUMAR, IVANNA V. TATARYN, K. H. LU, JEROME M. HERSHMAN, PETER EGGENA, MOHINDER P. SAMBHI and HOWARD L. JUDD

Departments of Medicine and Obstetrics and Gynecology, University of California Los Angeles,California 90024; the Medical Services of Wadsworth Veterans Administration Hospital, Los Angeles,California 90073; and Sepulveda Veterans Administration Hospital, Sepulveda, Californi 91343

Address requests for reprints to: Dr. Howard L. Judd, Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, UCLA School of Medicine, Los Angeles, California 90024.

To determine which dosage of estrogen might provide physiological replacement and also avoid possible harmful side effects, 21 postmenopausal women were studied before and after the oral administration of conjugated equine estrogens. The dosages studied were 0.15, 0.30, 0.625, and1.25 mg/day, with each being given for 6 weeks. Fifteen premenopausal women ere also studied, and their values were presumed to reflect normal physiological function

Variable responses of the different biochemical and biological markers of the action of estrogen were observed. Both LH and FS levels showed stepwise decreases with increasing amounts of estrogen, but even 1.25 mg;/day did notsuppress these hormones to the range found in premenopausawomen, suggesting a subphysiological response. The lower dosages of conjugated estrogen had minimal effects on vaginal cytology, withonly the 1.25-mg dose changing the maturation index to values similar to those found in premenopausa subjects. The 0.3-mg dose of conjugated estrogen was the lowest amount that resulted in a significant reduction (P <0.05) of the urinary calcium to creatinine ratio (an index of bone resorption).Liver protein synthesis was the most sensitive parameter to the action of estrogen. Hepatic responses were variable depending on which protein was assessed. These data indicate that the oral administration of conjugated equine estrogens results in inconsistent effects. All doses exerted subphysiological, physiological, and pharmacological responses at the different sites of action.

* This work was supported in part by USPHD Grants CA-23093, RR-865, and HD-7181 and V.A. Medical Research Funds.

Received January 10, 1980.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
H. J Teede, F. S Dalais, and B. P McGrath
Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women
Am. J. Clinical Nutrition, March 1, 2004; 79(3): 396 - 401.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. D. Utiger
Estrogen, Thyroxine Binding in Serum, and Thyroxine Therapy
N. Engl. J. Med., June 7, 2001; 344(23): 1784 - 1785.
[Full Text] [PDF]


Home page
NEJMHome page
J. L. Shifren, G. D. Braunstein, J. A. Simon, P. R. Casson, J. E. Buster, G. P. Redmond, R. E. Burki, E. S. Ginsburg, R. C. Rosen, S. R. Leiblum, et al.
Transdermal Testosterone Treatment in Women with Impaired Sexual Function after Oophorectomy
N. Engl. J. Med., September 7, 2000; 343(10): 682 - 688.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. I. Surks and R. Sievert
Drugs and Thyroid Function
N. Engl. J. Med., December 21, 1995; 333(25): 1688 - 1694.
[Full Text] [PDF]


Home page
JAMAHome page
R. Abbasi and G. D. Hodgen
Predicting the Predisposition to Osteoporosis: Gonadotropin-Releasing Hormone Antagonist for Acute Estrogen Deficiency Test
JAMA, March 28, 1986; 255(12): 1600 - 1604.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
S. G. Korenman
Menopausal Endocrinology and Management
Arch Intern Med, June 1, 1982; 142(6): 1131 - 1136.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society